Form 4 for NEO NEOGENOMICS INC
Accepted 2024-08-13 00:00:00 ET · period of report 2024-08-10 · accession 0001077183-24-000129 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-08-13 | 2024-08-10 | NEO | KANOVSKY STEPHEN M | Dir | M - OptEx | $0.00 | +11.3K | 36.1K | +46% | $0 |
| D | 2024-08-13 | 2024-08-10 | NEO | KANOVSKY STEPHEN M | Dir | M - OptEx | $0.00 | -11.3K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-10 | M | A | 11,336 | $0.00 | 36,090 | D | — | — | (F1) Reflects release of restricted stock units that were previously reported on a Form 4. |
| 2 | Derivative | Restricted Stock Unit | 2024-08-10 | M | D | 11,336 | $0.00 | 0 | D | $0.00 · 2024-08-10 to — | 11,336 Common Stock | (F2) Once vested, the shares of common stock are not subject to expiration. |